Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

SNW2:GR

43.546 EUR 0.504 1.14%

As of 09:59:09 ET on 02/26/2015.

Snapshot for Sanofi (SNW2)

Open: 43.697 Day's Range: 43.546 - 44.759 Volume: 350
Previous Close: 44.050 52wk Range: 34.905 - 45.270 1-Yr Rtn: +19.80%

Stock Chart for SNW2

No chart data available.
  • SNW2:GR 44.340
  • 1D
  • 1M
  • 1Y
44.050
Interactive SNW2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNW2

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 15.6584
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) 2.7810
Est. PEG Ratio 2.4874
Market Cap (M EUR) 114,906.35
Shares Outstanding (M) 2,638.74
30 Day Average Volume 245
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.27%
Cash Dividend (USD) 1.3354
Dividend Ex-Date 05/06/2015
5 Year Dividend Growth 3.30%
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNW2

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for SNW2

Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

Serge Daniel WeinbergInterim CEOAnne C BealChief Patient Officer
Elias A ZerhouniPres:Global Research & DevJerome ContamineExec VP/CFO
More Company Profile & Key Executives for SNW2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil